Trieu Vuong 4
4 · Oncotelic Therapeutics, Inc. · Filed Dec 7, 2022
Insider Transaction Report
Form 4
Trieu Vuong
DirectorCHAIRMAN AND CEO10% Owner
Transactions
- Purchase
Common Stock
2022-12-06$0.05/sh+120,000$6,000→ 90,558,021 total
Holdings
- 6,872,529(indirect: By Spouse)
Common Stock
- 16,780,384(indirect: By Autotelic, Inc.)
Common Stock